Stay informed. See MDA updates on COVID-19

Innovations in Care

We provide programs and services that transform the lives of people affected by neuromuscular disease.

Outside Organization Programs & Information

As part of our support to the neuromuscular disease community, MDA posts information provided by outside companies and organizations that are educational or research in nature.

The information, programs and resources listed below are not developed,  sponsored, funded or endorsed by MDA.  The companies and organizations posting below are responsible for all content and information provided. Any questions or queries, please email us at Posting may not be for fundraising or commercial purposes.

The ALS Association Michigan Chapter 2021 Statewide Virtual Symposium

Please join us for this free program featuring an opening presentation, a neurologist panel Q&A session, and additional featured speakers.  Zoom registration is required.  This symposium will be held on January 21, 2021 from 6-8:30 PM EST.  The agenda can be found here and the registration page here.  Questions?  Please contact Tanya Peterson at (616) 459-1900 or tanya@alsa-michigan.

Save The Date! Fighting for the Future: Education and Support for Familial FTD/ALS Virtual Conference

The Penn FTD Center will be hosting this virtual conference on Saturday, February 27, 2021 from 9AM-12PM.  The conference recognizes the unique challenges and situations that arise from familial or genetic disease and is designed to recognize and address these topics. You will have the chance to hear from genetic counselors, neurologists, and social workers on the genetics of FTD and ALS—and give you the chance to ask your questions in real-time. Please stay tuned for the meeting agenda and additional registration details. In the meantime, please reach out to Laynie Dratch (; 267.357.0761) with any questions.

Physical Therapy Webinar Series, Hosted by CureSMA

Cure SMA is hosting a Physical Therapy Webinar Series, sponsored by Biogen and The Luke 18:1 Foundation, which will provide information regarding exercise at home.  These 1-hour educational webinars will include presentations from licensed physical therapists who will discuss an array of home exercises available to adults and children with SMA.  Upon registration, attendees will also be mailed a resistance band set (limit 1 per affected individual in a household, 3 maximum). This versatile item is useful to strengthen muscles through a variety of both passive and active movements.
This event is intended for U.S. audiences only.  Please contact with any questions.
Disclaimer: Medical or legal opinions expressed or shared should not be substituted or interpreted as personal medical or legal advice. Please consult your healthcare provider regarding any health-related concerns.

Upcoming Events

Duchenne Quality of Life Survey Study

DeltaQuest Foundation is seeking participants for an important study about the impact of Duchenne Muscular Dystrophy on the family. DeltaQuest Is a not-for-profit research organization whose mission is to facilitate and implement innovative quality-of-life research. DeltaQuest Is seeking DMD caregivers, patients, and siblings ages 8 through adulthood. Participants will receive a generous payment for completing each survey.

For more information on this survey, please email Dr. Carolyn Schwartz at When emailing Dr. Schwartz, please include the following: Your name, how you heard about the study, and name(s) and age(s) of people with DMD in your household.

BIO is conducting a survey on the Impacts on COVID-Related Clinical Trial Alternations on Clinical Trial Participants.

This survey is being conducted by the Biotechnology Innovation Organization. We are hoping to hear from patients about how COVID-19 may have impacted or is currently impacting patients’ abilities to participate in clinical trials. Additionally, if trials have been altered, we are trying to better understand if the changes that have been implemented have reduced or added to the burden for patients participating in clinical trials. If you have any questions about this survey please contact Danielle Friend at We appreciate your participation! The survey results will be analyzed on a rolling bases beginning August 31, 2020. The questions outlined below apply only to experimental treatment trials, NOT natural history studies.


Background: For MG Awareness Month in partnership with patients we are excited to launch iMaGineMyMG. iMagineMyMG is a place for people living with and impacted by MG to listen, learn and connect with each other. Inspired and designed by people living with MG for people living with MG, iMaGineMyMG is a resource in learning more about MG. The site is filled with new ways to connect with others and share experiences, resources and information on life with MG. It includes opportunities to participate in monthly surveys, post videos and pictures and connect with others in the community. It also includes resources for individuals to talk with their doctors on improving their quality of life and the day to day experience of life with MG. We’ll be updating the site on a regular basis.

Exercise and CMT

The Charcot-Marie-Tooth Association in collaboration with Therapies for Inherited Neuropathies created a series of physical therapy centered videos to help CMT patients in the areas of flexibility, balance, strengthening, endurance and function.

No Charge Genetic Testing for Patients Suspected of Having SMA

The SMA Identified Program offers no charge genetic testing for patients suspected of having or clinically diagnosed with SMA.  The link to the program is below:

Take on Thymidine Kinase 2 deficiency (TK2d)

Whether you're living with an MDS, have been diagnosed with TK2d or are a parent, caregiver, or healthcare professional (HCP) who wants to learn more about MDS and TK2d, visit for more information. We can all take on TK2d together.

Gene Therapy Patient Education

The American Society of Gene and Cell Therapy has a variety of educational resources available on their website. Visit to learn more about the basics of gene therapy, the clinical trial process and the potential of gene therapy for specific diseases including SMA and MTM.